Article info
PDFClinical and epidemiological research
Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer
- Correspondence to Dr. Ami A Shah, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA; Ami.Shah{at}jhmi.edu
Citation
Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer
Publication history
- Received January 11, 2018
- Revised March 20, 2018
- Accepted March 29, 2018
- First published April 20, 2018.
Online issue publication
July 12, 2018
Article Versions
- Previous version (20 April 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.